We are very pleased to share our 2023 #AnnualReport – Future Ready. We hope you will read it and share it. You can find it on our website: https://lnkd.in/gE8_Cxf Peruse the pages to read about our partnerships, projects, portfolio companies, people (like our terrific Board of Directors) and progress. Shoutouts (and thanks!): Networks of Centres of Excellence, Government of Canada, OmniaBio, McMaster Innovation Park, CCRM Nordic, CCRM Australia, Canadian Advanced Therapies Training Institute, University of Toronto, Centre de production de produits biologiques (CPPB) inc. / Biologics Manufacturing Centre (BMC) Inc., Jim Wilson, Peter Zandstra, McMaster University, Mohawk College, Catamaran Bio, Ontario Veterinary College, University of Guelph, The University of Queensland, Multiplex, Visions of Science , Vinnova, GoCo Health Innovation City, Glenn MacLean, Sarah Lepage, Medicine by Design - University of Toronto, Stem Cell Network and more!!!
CCRM
Biotechnology Research
Toronto, Ontario 23,157 followers
Commercializing Living Therapies
About us
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.
- Website
-
http://www.ccrm.ca
External link for CCRM
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Toronto, Ontario
- Type
- Nonprofit
- Founded
- 2011
- Specialties
- Commercialization, Cell Reprogramming, Cell Manufacturing, Biomaterials + Tissue Mimetics, Integration of Science + Business, Industry Consortium, and Contract Services
Locations
-
Primary
MaRS Centre, West Tower
661 University Ave., Suite 1002
Toronto, Ontario M5G 1M1, CA
-
Employees at CCRM
-
Sherif Sheta
CIO in Cell & Gene Therapy - CCRM | OmniaBio
-
Louis Rogers PhD PMP DTM
-
Phil Vanek
Chief Technology Officer at Gamma Biosciences
-
Valorie Tutt
Legal and Regulatory Leader within both Private and Public Sector | Negotiator | Governance | Policy | Business Partner | Healthcare | Procurement…
Updates
-
This week's post on Signals profiles Jacqui Getfield, PhD, program manager with Caribbean African Regenerative Medicine (CARM). CARM is founded on the work of Istvan Mucsi, University Health Network, and is co-led by Carl James, York University. CARM received funding support from Medicine by Design - University of Toronto Read her interesting story here: https://lnkd.in/gikVQffH
-
CCRM reposted this
Summer by Design will be back from June 2-11! The #MedicinebyDesign program (with lead partner, CCRM, as well as Stem Cell Network and University of Toronto - Rotman School of Management) prepares Canadian and international PhD students and post-docs to enter the industry with the skills needed to commercialize regenerative medicine. Build your international network and join us on campus at #UofT for 8 days of immersive programming featuring expert-led, interactive sessions covering a range of topics including: product conceptualization and de-risking, technology strategy and IP, regulatory affairs, marketing and strategic communications and pitching. Apply by Dec 20: https://lnkd.in/gNs5_t_4 Check out testimonials of Summer by Design alumni here! https://lnkd.in/g3AHDh_y
-
CCRM reposted this
Congratulations to OmniaBio on the grand opening of their new cell and gene manufacturing facility in Hamilton, Ontario. https://lnkd.in/g46Dnxuf The new biomanufacturing facility in Hamilton will help take Ontario-made transformative therapies to the market. #lifesciences #cellandgenetherapy #manufacturing cc: Mitchel Sivilotti, CCRM, McMaster Innovation Park
-
CCRM is thrilled to announce the grand opening of OmniaBio's new North American #CGT manufacturing and #AI centre of excellence, which is now Canada’s largest #CDMO facility dedicated to CGT. CCRM's vision and efforts to build a thriving regenerative medicine ecosystem in Canada has always included manufacturing. First we built the Centre for Advanced Therapeutic Cell Technologies with Cytiva and the Government of Canada (2016) to industrialize cell manufacturing; next it was the Centre for Cell and Vector Production with University Health Network (2019), a #GMP facility for Phase I and II in-human clinical trials; and the culmination of this effort is our subsidiary, OmniaBio, and the facility at McMaster Innovation Park, with the capacity and capabilities for Phase III and commercial manufacturing. It's an exciting day for patients in Canada and worldwide. Thank you to our employees and colleagues at OmniaBio for all their hard work. Thank you to our partner MEDIPOST America, Inc. 메디포스트 MEDIPOST and to Invest Ontario for their funding support and investment in 2022 that allowed us to get the facility built. Please read the news release: https://lnkd.in/gSW7rKAg Doug Ford, Victor Fedeli, ONeconomy | ÉconomieON, Justin Trudeau, François-Philippe Champagne, Federal Economic Development Agency for Southern Ontario | Agence fédérale de ..., Networks of Centres of Excellence
-
Thank you NGen Canada for this feature about OmniaBio and CCRM, and the important work we are doing to advance cell and gene therapies in Canada, with your support. https://lnkd.in/gDRPB5g4
-
CCRM reposted this
🚀 Attention Startups! The Countdown Begins! 🚀 Submissions for the Start-Up Award at the Advanced Therapies Awards, sponsored by CCRM, are officially closing soon! If you're a startup driving innovation and pushing the boundaries of advanced therapies, this is your chance to be recognized and celebrated. The countdown to the 18th October deadline has begun—don’t miss your opportunity to showcase your work on the global stage! ✨ Bonus: Submit your entry and receive a 10% discount on your Advanced Therapies Week pass! 🔗 Submit your entry now: https://lnkd.in/e-2sAA4B Let’s recognize the rising stars shaping the future of advanced therapies! #StartUps #AdvancedTherapiesAwards #CCRM #Innovation #ATW25 #Biotech #Leadership
-
Congratulations to this year’s #CellsISee People’s Choice Award winner, Sanjana Grover, University of Manitoba, for “The Power to Produce in Assortment.” Cells I See is hosted by CCRM and Stem Cell Network as part of the Till & McCulloch Meetings (TMM). Sanjana Grover will receive the prize award at TMM2024 in Montreal. Thank you to everyone who submitted their work!
-
Blogger Lyla El-Fayomi is back with #regenerativemedicine news highlights from September. Catch up here https://lnkd.in/djt7kgNi Read about Dr. Clara Chan's (University Health Network) important work to treat vision loss. #IBD #crohns #colitis #vision Image credit: Cincinnati Children's
Regenerative medicine news under the microscope – September 2024
https://www.signalsblog.ca
-
Welcome Stephanie Mattsson, we're delighted to have you! Having secondments was always part of the vision of these CCRM hubs and it's exciting to see this come to fruition. It's a good thing you are used to winter....
Captain, steer towards Canada! 🇨🇦🛫 CCRM Nordic is making its first secondment. Our Director of Venture Development Stephanie Mattsson is leaving today and will join the CCRM Toronto office. This is a great opportunity to work on projects across the CCRM hubs and an important piece of support for the continued development of the #CCRMNordic organization. #Canada #businessdevelopment #collaboration #innovation #VentureCapital #Sustainability #careerdevelopment